Last updated: 2026-09-04 23:54:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
TuHURA Biosciences, Inc. (HURA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2,13, with a market capitalization of $133,19M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,41 to $3,43. This page covers its latest market performance, valuation, price trends and company information.
$133,19M | |
$2,09 | |
$7,93 | |
$0,41 | |
$2,10 | |
360,71K | |
-- | |
-- | |
$3,43 | |
$0,41 | |
0,01% | |
-- |
TuHURA Biosciences, Inc. (HURA) is trading at $2,10 in after-hours trading as of 2026-09-04 23:31:00, unchanged from the regular-session close of $2,10.
After-hours trading shows how investors are pricing HURA after the regular session closes. The current after-hours price is near the regular-session close, indicating neutral after-hours sentiment.
Over the past seven days, TuHURA Biosciences, Inc. (HURA) moved from $2,12 to $2,13, representing a gain of 0,61% ($0,01).
The stock traded between $2,06 and $2,16 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 172,77 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 57,1%
HURA is currently trading at $2,13, placing it 57,1% of the way from its 52-week low of $0,41 to its 52-week high of $3,43. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 22 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of TuHURA Biosciences, Inc. (HURA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.